These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5574568)
1. [New chemotherapeutics in hematology]. Klener P Vnitr Lek; 1971 Mar; 17(3):249-54. PubMed ID: 5574568 [No Abstract] [Full Text] [Related]
2. [Antibody therapy in hematology and oncology--2]. Kneba M; Schrader C; Köhne H Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594 [No Abstract] [Full Text] [Related]
3. [Possibilities and limits of polychemotherapy in hematology]. István L Orv Hetil; 1982 Nov; 123(47):2879-85. PubMed ID: 7177635 [No Abstract] [Full Text] [Related]
4. [Bone necrosis as a sequela of chemotherapy in hematologically malignant disorders]. Pieters R; Taets van Amerongen AH; van Brenk AI; Veerman AJ Ned Tijdschr Geneeskd; 1989 Oct; 133(43):2117-22. PubMed ID: 2682283 [No Abstract] [Full Text] [Related]
5. [Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations]. Hanauske AR Med Klin (Munich); 1996 Apr; 91 Suppl 3():68-70. PubMed ID: 8692122 [No Abstract] [Full Text] [Related]
6. [The treatment of chronic hemoblastosis with new cytostatic agents]. Quattrin N Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017 [No Abstract] [Full Text] [Related]
7. Metabolic complications of induction therapy for leukemia and lymphoma. Cohen DG Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111 [No Abstract] [Full Text] [Related]
8. Chemotherapy of Hodgkin's disease, lymphoma, and leukemia. Bishop RC Radiol Clin North Am; 1968 Apr; 6(1):91-5. PubMed ID: 5652936 [No Abstract] [Full Text] [Related]
9. [Chemotherapy in lymphoproliferative syndromes]. Berumen LJ Rev Med Hosp Gen (Mex); 1965 Apr; 28(4):287-97. PubMed ID: 5838577 [No Abstract] [Full Text] [Related]
10. Case report. Effect of antineoplastic chemotherapy on cervical cytology. Nelson J; Makary AZ; Kough RH Pa Med; 1979 May; 82(5):44-6. PubMed ID: 460908 [No Abstract] [Full Text] [Related]
11. [Drugs needed for treatment of patients with hemoblastosis]. Lebedev VN; Sarkisian SP Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):45-8. PubMed ID: 877053 [No Abstract] [Full Text] [Related]
12. Developments in the treatment of leukaemias and lymphomas. Ann Hematol; 1995 Jun; 68(3 Suppl):1-8. PubMed ID: 7619921 [No Abstract] [Full Text] [Related]
13. [Application of bis-diketopiperazine in the treatment of acute leukemia and other malignant blood disorders]. Yang QE; Zhang A Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):17-20. PubMed ID: 6238688 [No Abstract] [Full Text] [Related]
14. Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas. Tallman MS Semin Hematol; 2008 Jul; 45(3 Suppl 2):S1. PubMed ID: 18760703 [No Abstract] [Full Text] [Related]
15. American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USA. Talmadge JE IDrugs; 2007 Feb; 10(2):87-9. PubMed ID: 17285455 [No Abstract] [Full Text] [Related]
16. Second malignancies and chemotherapeutic agents. Kyle RA Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671 [No Abstract] [Full Text] [Related]